Second-line chemotherapy for the treatment of metastatic pancreatic cancer after first-line gemcitabine-based chemotherapy: a network meta-analysis

Guidelines for treatment of metastatic pancreatic cancer recommend a second line based on Fluoropyrimidine (FP) alone or in combination with Oxaliplatin (OXA) or Irinotecan (IRI) after a first line treatment based on Gemcitabine (GEM). We conducted a Bayesian network meta-analysis to compare current...

Descripción completa

Detalles Bibliográficos
Autores principales: Citterio, Chiara, Baccini, Michela, Orlandi, Elena, Di Nunzio, Camilla, Cavanna, Luigi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6049864/
https://www.ncbi.nlm.nih.gov/pubmed/30038721
http://dx.doi.org/10.18632/oncotarget.25639

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6049864/
https://www.ncbi.nlm.nih.gov/pubmed/30038721
http://dx.doi.org/10.18632/oncotarget.25639

Ejemplares similares